SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models
Zylkiewicz, E, Rzymski, T, Mikula, M, Dreas, A, Wiklik, K, Wrobel, A, Golas, A, Dolata, I, Wojcik, K, Masiejczyk, M, Statkiewicz, M, Kuklinska, U, Goryca, K, Grochowsk, A, Cabaj, A, Bialas, A, Mikulski, M, Windak, R, Ostrowski, J, Brzozka, K
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
RVU120, a small molecule inhibitor of CDK8/19 kinases, enhances rituximab-driven NK cells-mediated cytotoxicity both in vitro and in vivo
Białopiotrowicz-Data, E., Dziedzic, K., Podkalicka, P., Grycuk, K., Gołas, A., Dolata, I., Chmielewski, S., Pilch, Z., Nowis, D., Juszczyński, P., Rzymski, T.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
402 - SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models
Zylkiewicz, E., Rzymski, T., Mikula, M., Dreas, A., Wiklik, K., Wrobel, A., Golas, A., Dolata, I., Wojcik, K., Masiejczyk, M., Statkiewicz, M., Kuklinska, U., Goryca, K., Grochowsk, A., Cabaj, A., Bialas, A., Mikulski, M., Windak, R., Ostrowski, J., Brzozka, K.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article